Rubella Vaccine
Overview
Rubella Vaccine is a freeze dried preparation of a suitable live attenuated strain of rubella virus grown in human diploid cell cultures. Rubella Vaccine is indicated for active immunization against rubella virus (German measles) to prevent or control outbreaks of rubella in childrens 12 month of age or older and adults.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
The symptomatic adverse reactions produced by Rubella Vaccine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Fever, Skin rashes, Pharyngitis.
Back to top
Dosage
Rubella Vaccine's dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
0.5 ml | 0.5 (0.5) | 24 hourly | IM,SC | For females only. |
Paedriatic Dosage (20kg)
|
0.5 ml | 0.5 (0.5) | As recommended. | Intra Muscular | For Once |
0.5 ml | 0.5 (0.5) | As recommended. | Subcutaneous | For Once |
Neonatal Dosage (3kg)
|
No data regarding the neonatal dosage details of Rubella Vaccine is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Rubella Vaccine
Back to top
Manufacturers of
Rubella Vaccine
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic